INTRODUCTION
Label-free technologies have proven to be powerful for characterizing biomolecular interactions to define a complete picture of biochemical intricacies of cellular systems. From a biochemical and biophysical point of view, the formation of a complex when two molecules interact may be quite complicated and largely depends on the type of noncovalent bonds defined by kinetic and thermodynamic parameters. Many types of optical biosensors and isothermal titration calorimeters are now used routinely to quantitatively determine the binding affinities, kinetics, and other thermodynamic parameters of molecular interactions in real time without use of a molecular label. These tools allow us to define proteinprotein, protein-nucleic acid, antigen-antibody, and protein-small molecule interactions to high accuracy.
These technologies have also taken a center stage for high-throughput screening of antibodies and small molecules in drug development. The aims of this MIRG survey were to assemble a profile of label-free technologies used in molecular interaction analysis, compare their current status with the survey results that were recorded previously by the MIRG in 2007, 1 and perhaps provide some insight as to where this technology is going. Currently, two entirely different technologies dominate the field, namely, isothermal titration calorimetry (ITC) and biosensors, such as surface plasmon resonance (SPR), biolayer interferometry (BLI), and quartz crystal microbalance (QCM). In addition, it is unknown how accurate these techniques are in practice across multiple laboratories having varied levels of expertise. The MIRG began looking at some of these variables in this year's study.
The MIRG of the Association of Biomolecular Resource Facilities (ABRF) was established with a mission to educate member laboratories on advances in these technologies. The MIRG has launched surveys in the past on several technologies used to quantitatively measure molecular interactions. 1 The main goal of this particular survey was to take a snapshot of the rapidly evolving field of label-free biosensors and ITC to evaluate the following aspects:
• type of laboratories that use biosensors, ITC and other technologies, i.e., academic, industry, nonprofit, or commercial
• type of instrumentation used • what kind of biophysical parameters are measured • confidence in data interpretation • data validation and acceptability • limitations of using biosensors and ITC From the results of this survey, participating laboratories and vendors will be able to assess their own capabilities.
Users will gain insight into the relative confidence in using various instruments and data interpretation.
METHODOLOGY
A web-based general survey using Survey Monkey on biosensors and ITC was conducted to gauge the current profiles of academic, industry, nonprofit research institutions, and commercial laboratories who use these biophysical technologies. For analyzing protein structure and function, clearly, there is no one-size-fits-all approach. The survey consisted of questions related to the type of laboratory, type of label-free technology used in the laboratory, and application of the technology. The survey also had specific questions on SPR technology, BLI, ITC, and other label-free biosensor technologies. The survey questions were posted on the website www. surveymonkey.com. The launch of the survey announcement was e-mailed to all ABRF members and to other laboratories that use label-free technologies to measure molecular interactions. The survey was launched on January 14, 2011, and the data received until February 11, 2011. The participating laboratories were asked to answer 20 questions about various aspects of these technologies; a final question, 21, was optional: What new or improved capability would be most valuable to your laboratory in studying biomolecular interactions? The question was meant to get feedback from users about making improvements in the technology that currently exists in the marketplace or innovation that does not currently exist in the marketplace but would be useful. In total, 82 laboratories that use various label-free technologies responded.
RESULTS
A summary of observations made from the survey responses is displayed in Table 1 . 
DISCUSSION
In the 2011 MIRG survey, over two-thirds (69.5%) of the respondents who use label-free technologies were from industry (Pharma or Biotech), 17.1% were from academia. This is a shift compared to the previous 2007 survey where 50% of respondents were from academia and only 31.3% were from industry. The most widely used label free technology was SPR (79.2%), followed by BLI (44.2%), then ITC (31.2%). This is also a change from the 2007 survey results, where ITC was the most widely used technique (68.5%), closely followed by SPR (56.2%). BLI was not included as a specific option in the 2007 survey. It will be interesting to follow how widespread newer technologies become in future surveys.
The label-free technologies are used for various purposes, yet most respondents measured binding affinities (97.6%), closely followed by binding kinetics (79.5%). Stoichiometry and concentration analysis were approximately equal (47.3% and 46.7% respectively), while thermodynamic parameters were the least commonly measured (28.9%). In the 2007 survey the trend was similar with 79% of respondents recording binding affinity as the highest importance. However, stoichiometry was previously the next most desired parameter (47.0%) followed by association and dissociation kinetics (40.0%).
Of the type of interactions measured in 2011, proteinprotein and antigen-antibody were by far the most common (92.6% and 72.8% respectively), followed by protein-small molecule (53.1%). In 2007 protein-protein interactions were also the major interaction sub-class (88.0%). However, protein-small molecule were the next (76.0%) followed by antigen-antibody (42.7%).
In the present survey more users of SPR had high confidence in the measured affinity values (73.9%), followed next by ITC (51.3%) and BLI (43.2%). This is a significant shift from 2007, where most users of ITC (77.0%) had high confidence in affinity values, followed by AUC (44%) and SPR (33%). In 2011 the majority of users occasionally cross validated results and only 23. In response to the optional question 21, users were asked what new or improved capability would be of most value. Of the 24 respondents who answered this question suggestions included: higher throughput calorimeters and biosensors, greater sensitivity, lower cost of instrumentation, and reduced artifacts associated with small molecular screening.
